This inventor holds 5 USPTO granted patents. Top assignees: Warner-Lambert Company, Astellas Pharma Gmbh. Active years: 1999-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2007
Title: Milton Lethan Pressler: Innovator in Cardiovascular Treatments
Introduction
Milton Lethan Pressler is a notable inventor based in Saline, MI (US). He has made significant contributions to the field of medicine, particularly in the treatment of cardiovascular conditions. With a total of 5 patents to his name, Pressler's work has had a meaningful impact on patient care.
Latest Patents
Pressler's latest patents focus on innovative treatments for congestive heart failure and pulmonary hypertension. One of his key inventions involves the use of combinations of diuretics and vasopressin antagonists to slow and reverse the symptoms of congestive heart failure. This method aims to increase the excretion of water in urine while decreasing the excretion of sodium and potassium ions. Additionally, he has developed a method for treating pulmonary hypertension using a vasopressin antagonist, showcasing his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Pressler has worked with prominent companies in the pharmaceutical industry, including Warner-Lambert Company and Astellas Pharma GmbH. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Pressler has collaborated with notable colleagues such as Joseph Thomas Peterson, Jr. and Rebecca Guggemos Bakker-Arkema. These partnerships have further enriched his work and expanded the scope of his inventions.
Conclusion
Milton Lethan Pressler's contributions to the medical field through his patents and collaborations highlight his dedication to improving treatments for cardiovascular diseases. His innovative approaches continue to influence the industry and enhance patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
